Salicylaldehyd, min. 99 %, zur Synthese, 100 ml, Glasverpackung

4-Cyano-tetrahydropyran-4-carboxylic acid, 95.0%, 10g

2,3,4,5-Tetrahydro-1H-benzo[c]azepine hydrochloride, 95.0%, 5g

1-[(4-Methylphenyl)sulfonyl]-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 98%, 100mg

1,2-Difluoro-4-methoxy-5-nitrobenzene, 98+%, 1g

Methyl 10-bromodecanoate, 97%, 5g

Methyl 2-amino-4-isobutylthiophene-3-carboxylate, 95%, 2.5g

2-Methoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 1g

4,5-Difluoro-2-nitrotoluene, 96.0%, 5g

3-Chloro-2-naphthoic acid, 1g

5-(4-Pyridyl)-1,3,4-thiadiazol-2-yl-amine, 99.0%, 5g

2-tert-Butylbenzoic acid, 97.0%, 250mg

Benzyltrimethylammonium dichloroiodate, 95.0%, 500g